IDV vehicle
36E79724D0021
NEW AWARD FOR DPP-4 SITAGLIPTIN WITH ZYDUS PHARMACEUTICALS (USA)INC. PERIOD OF PERFORMANCE IS 5/18/2024 - 5/17/2025 WITH FOUR ONE-YEAR OPTION PERIODS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $113.8M |
| Start date | May 18, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 9, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2026 | P00011 | $0 | MODIFICATION TO INCORPORATE SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APR 2026), INTO THE CONTRACT. |
| Apr 15, 2026 | P00010 | $0 | EXERCISE OPTION YEAR TWO FOR 36E79724D0021 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 5/18/2026 - 5/17/2027. |
| Jan 14, 2026 | P00009 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE ZYDUS'S 2026 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2026 - DECEMBER 31, 2026. |
| Dec 8, 2025 | P00008 | $0 | INCORPORATE 2026 FEDERAL CEILING PRICE IAW PUBLIC LAW 102-585 FOR DPP-4 SITAGLIPTIN TABLETS WITH ZYDUS PHARMACEUTICALS USA, INC. NO PRICE CHANGES TO THE NATIONAL CONTRACT. |
| Apr 22, 2025 | P00007 | $0 | EXERCISE OPTION YEAR ONE FOR 36E79724D0021 WITH NO PRICE CHANGES. THE PERIOD OF PERFORMANCE IS 5/18/2025 - 5/17/2026. |
| Apr 17, 2025 | P00006 | $0 | INCORPORATE 2025 FEDERAL CEILING PRICE IAW PUBLIC LAW 102-585 FOR DPP-4 SITAGLIPTIN TABLETS WITH ZYDUS PHARMACEUTICALS USA, INC. NO PRICE CHANGES TO THE NATIONAL CONTRACT. |
| Apr 3, 2025 | P00005 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE ZYDUS 2025 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2025 - DECEMBER 31, 2025. |
| Nov 20, 2024 | P00004 | $0 | BOTH THE 30 COUNT BOTTLES AND 90 COUNT BOTTLES WILL REMAIN ON THE CONTRACT 36E79724D0021.THE 90 COUNT BOTTLES ARE NOT REPLACING THE 30 COUNT BOTTLES. THE 90 COUNT BOTTLES WERE ADDED AS AN ALTERNATE BOTTLE SIZE. |
| Oct 29, 2024 | P00003 | $0 | 3 NDC ADDITIONS TO 36E79724D0021. THE 90CT BOTTLES WILL BE AT THE SAME PER TABLET PRICE AS THE 30CT BOTTLES. PERIOD OF PERFORMANCE IS EFFECTIVE 10-30-2024-05-17-2025. THE OLD NDC"S WILL REMAIN ON CONTRACT UNTIL THE PRODUCT HAS BEEN FULLY DEPLETED. |
| Sep 18, 2024 | P00002 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE ZYDUS 2024 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2024 - DECEMBER 31, 2024. |
| Apr 4, 2024 | P00001 | $0 | MODIFICATION FOR THE SUPPLEMENTAL CHANGES TO THE CRF PAYMENT SUBMITTAL AND SALES REPORTING REQUIREMENTS. |
| Mar 18, 2024 | 0 | $0 | NEW AWARD FOR DPP-4 SITAGLIPTIN WITH ZYDUS PHARMACEUTICALS (USA)INC. PERIOD OF PERFORMANCE IS 5/18/2024 - 5/17/2025 WITH FOUR ONE-YEAR OPTION PERIODS. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Michael J Olszewski | Contract Specialist | Michael.Olszewski@va.gov | Source | Dec 5, 2023 |
| Michael J Olszewski | Contract Specialist | Michael.Olszewski@va.gov | Source | Nov 16, 2023 |
| Michael J Olszewski | Contract Specialist | Michael.Olszewski@va.gov | Source | Nov 7, 2023 |
| Michael J Olszewski | Contract Specialist | Michael.Olszewski@va.gov | Source | Oct 24, 2023 |
| michael.olszewski@va.gov | Michael Olszewski | michael.olszewski@va.gov 708-786-4966 | Source | Oct 5, 2023 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.